Risk factors for severe complications of colonoscopy in screening programs

Please use this identifier to cite or link to this item: http://hdl.handle.net/10045/87432
Información del item - Informació de l'item - Item information
Title: Risk factors for severe complications of colonoscopy in screening programs
Authors: Vanaclocha-Espi, Mercedes | Ibáñez, Josefa | Molina-Barceló, Ana | Valverde-Roig, María José | Pérez, Elena | Nolasco, Andreu | Vega, Mariola de la | Diez de la Lastra-Bosch, Isabel | Oceja, María Elena | Espinàs, Josep Alfons | Font, Rebeca | Pérez-Riquelme, Francisco | Arana-Arri, Eunate | Portillo, Isabel | Salas, Dolores | CRIBEA Group
Research Group/s: Grupo Balmis de Investigación en Salud Comunitaria e Historia de la Ciencia
Center, Department or Service: Universidad de Alicante. Departamento de Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia
Keywords: SC, Severe complication | CRC, Colorectal Cancer | CRCSP, Colorectal cancer screening programs
Knowledge Area: Enfermería
Issue Date: Jan-2019
Publisher: Elsevier
Citation: Preventive Medicine. 2019, 118: 304-308. doi:10.1016/j.ypmed.2018.11.010
Abstract: Severe complications (SC) in colonoscopy represent the most important adverse effect of colorectal cancer screening programs (CRCSP). The objective is to evaluate the risk factors for SC in colonoscopy indicated after a positive fecal occult blood test in population-based CRCSP. The SC (n = 161) identified from 48,730 diagnostic colonoscopies performed in a cohort of all the women and men invited from 2000 to 2012 in 6 CRCSP in Spain. A total of 318 controls were selected, matched for age, sex and period when the colonoscopy was performed. Conditional logistic regression models were estimated. The analysis was performed separately in groups: immediate-SC (same day of the colonoscopy); late-SC (between 1 and 30 days after); perforation; and bleeding events. SC occurred in 3.30‰ of colonoscopies. Prior colon disease showed a higher risk of SC (OR = 4.87). Regular antiplatelet treatment conferred a higher risk of overall SC (OR = 2.80) and late-SC (OR = 9.26), as did regular anticoagulant therapy (OR = 3.47, OR = 7.36). A history of pelvic-surgery or abdominal-radiotherapy was a risk factor for overall SC (OR = 5.03), immediate-SC (OR = 8.49), late-SC (OR = 4.65) and perforation (OR = 21.59). A finding of adenoma or cancer also showed a higher risk of overall SC (OR = 8.71), immediate-SC (OR = 12.67), late-SC (OR = 4.08), perforation (OR = 4.69) and bleeding (OR = 17.02). The risk of SC doesn't vary depending on the type of preparation or type of anesthesia. Knowing the clinical history of patients such as regular previous medication and history of surgery or radiotherapy, as well as the severity of the findings during the colonoscopy process could help to focus prevention measures in order to minimize SC in CRCSP.
Sponsor: This Project was funded by the Instituto de Salud Carlos III with co-funding from FEDER [PI12/00944].
URI: http://hdl.handle.net/10045/87432
ISSN: 0091-7435 (Print) | 0091-7435 (Online)
DOI: 10.1016/j.ypmed.2018.11.010
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2018 Elsevier Inc.
Peer Review: si
Publisher version: https://doi.org/10.1016/j.ypmed.2018.11.010
Appears in Collections:INV - BISCHA - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
Thumbnail2019_Vanaclocha-Espi_etal_PreventMed_final.pdfVersión final (acceso restringido)201,98 kBAdobe PDFOpen    Request a copy

Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.